BAP1 and mesothelioma: Taken together, these findings suggest that mesothelioma cells with a loss-of-function mutation in Bap1 are dependent on metabolic pathways such as the mevalonate pathway, which may eventually contribute to the pathogenesis of Bap1-deficient mesothelioma.